Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Unknown 4Terminated 1Completed 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Colorectal Neoplasms 117Colonic Neoplasms 30Neoplasm Metastasis 28Rectal Neoplasms 27Neoplasms 27Carcinoma, Non-Small-Cell Lung 14Esophageal Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Pancreatic Neoplasms 9Head and Neck Neoplasms 9Lung Neoplasms 8Cholangiocarcinoma 7Colorectal Cancer Metastatic 6Carcinoma, Squamous Cell 6Breast Neoplasms 6Carcinoma 5Triple Negative Breast Neoplasms 4Recurrence 4Prostatic Neoplasms 4Ovarian Neoplasms 4Inflammatory Breast Neoplasms 3Gastrointestinal Neoplasms 3Adenocarcinoma Of Esophagus 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Solid Tumors 2Kidney Neoplasms 2Glioma 2Fallopian Tube Neoplasms 2

Interventions

Bevacizumab 19Capecitabine 15Oxaliplatin 11Irinotecan 11Cetuximab 11Fluorouracil 10Leucovorin 8aflibercept 7Panitumumab 6trifluridine tipiracil drug combination 4Nivolumab 4sintilimab 3regorafenib 3Ipilimumab 3Vemurafenib 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Folfox protocol 2Drug Therapy 2tremelimumab 1spartalizumab 1raltitrexed 1pembrolizumab 1monoclonal antibody YYB-101 1masitinib 1irinotecan sucrosofate 1glucopyranosyl lipid-A 1folfirinox 1durvalumab 1camrelizumab 1balstilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Colorectal Cancer Metastatic × Panitumumab × Clear all
NCT06332079 2026-01-05

HAITI

Gruppo Oncologico del Nord-Ovest

Phase 2 Terminated
4 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03164655 2024-10-01

SULTAN

UNICANCER

Phase 2 Completed
20 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT01910610 2024-03-12

STRATEGIC-1

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Unknown
464 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT04169347 2023-07-27

FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer

Criterium, Inc.

Phase 2 Unknown
27 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03751176 2021-06-30

BEYOND

Grupo Espanol Multidisciplinario del Cancer Digestivo

Phase 2 Unknown
31 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03923036 2019-04-22

AVOCETTE

University Hospital, Caen

Unknown
2,000 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡